FMC (FMC) Prelim Q3 2026 (USD): Adj. EBITDA (565mln)-(510mln) (exp. +155.6mln), Revenue (65mln)-(125mln) (exp. +868.5mln)

Guidance of this shape, revenue near zero and EBITDA deeply negative against expectations of a solidly profitable quarter, is not a demand miss in the ordinary sense and reads instead as a structural discontinuity: the separation, divestiture or discontinued-operations treatment of a major segment, or an accounting reclassification, rather than a sudden collapse in volumes. FMC has been in the middle of portfolio restructuring, and prints framed as 'prelim' with ranges this wide typically accompany a transaction announcement or a restated reporting perimeter, with the cleaned-up detail arriving later. The established sequence in comparable episodes is an initial sharp gap on the headline gap versus consensus, followed by a partial retrace once the conference materials clarify what is continuing operations versus what is leaving the perimeter; comparability of prior consensus is usually the first casualty, since street models priced the old perimeter. What distinguishes outcomes in past cases is whether the residual business carries the balance sheet: leverage against the smaller EBITDA base is the transmission channel into credit and, in extremis, into the rating agencies' review calendars. The tells are the accompanying release language on perimeter changes, any simultaneous announcement on asset sales or leadership, and whether guidance is withdrawn altogether, which in past episodes of this kind has extended the de-rating well beyond the first session.